Mariana Teixeira Rodrigues

Dr. Mariana Teixeira Rodrigues

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
MRMariana Teixeira Rodrigues
Mariana Teixeira Rodrigues
AMAna Paula Picaro Michelli
Ana Paula Picaro Michelli
GCGustavo Felisola Caso
Gustavo Felisola Caso
POPaloma Ramos de Oliveira
Paloma Ramos de Oliveira
DRDorival Mendes Rodrigues-Junior
Dorival Mendes Rodrigues-Junior
IRIleana Rubio
Ileana Rubio
Anaplastic thyroid cancer (ATC) is an aggressive form of thyroid cancer (TC), accounting for 50% of total TC-related deaths. Although therapeutic approaches against TC have improved in recent years, the survival rate remains low, and severe adverse effects are commonly reported. However, unexplored alternatives based on natural compounds, such as lysicamine, an alkaloid found in plants with established cytotoxicity against breast and liver cancers, offer promise. Therefore, this study aimed to explore the antineoplastic effects of lysicamine in papillary TC (BCPAP) and ATC (HTH83 and KTC-2) cells. Lysicamine treatment reduced cell viability, motility, colony formation, and AKT activation while increasing the percentage of necrotic cells. The absence of caspase activity confirmed apoptosis-independent cell death. Necrostatin-1 (NEC-1)-mediated necrosome inhibition reduced lysicamine-induced necrosis in KTC-2, suggesting necroptosis induction via a reactive oxygen species (ROS)-independent mechanism. Additionally, in silico analysis predicted lysicamine target proteins, particularly those related to MAPK and TGF-β signaling. Our study demonstrated lysicamine’s potential as an antineoplastic compound in ATC cells with a proposed mechanism related to inhibiting AKT activation and inducing cell death.

30 June 2020 in Molecules
Verified
Journal Article
Open access
PDF file
LCLhaís Araújo Caldas
Lhaís Araújo Caldas
MRMariana Teixeira Rodrigues
Mariana Teixeira Rodrigues
ABAndrea N. L. Batista
Andrea N. L. Batista
JJJoão Marcos Batista Junior
João Marcos Batista Junior
JLJoao Henrique Ghilardi Lago
Joao Henrique Ghilardi Lago
PSPatricia Sartorelli
Patricia Sartorelli
This work describes the chromatographic fractionation of the aerial parts of Calea pinnatifida and the structural characterization and determination of the absolute configuration of the isolated compounds as well as their antitumor potential. The HPLC fractionation of the CH2Cl2 phase of the MeOH extract from the leaves of C. pinnatifida led to the isolation of two related sesquiterpene lactones (STLs): calein C (1) and calealactone B (2). Additionally, during the purification process, a derivative of calein C (3) was formed as a product of the Michael addition of MeOH. The structures of Compounds 1–3 were established based on spectroscopic and spectrometric data, while the absolute stereochemistry was established by vibrational circular dichroism. In order to evaluate the effect of the conjugated double bonds on the cytotoxic activity of STLs, Compounds 1–3 were tested against anaplastic (KTC-2) and papillary (TPC-1) thyroid carcinoma cells. Calein C was the most active of the STLs, and displayed activity against both KTC-2 and TPC-1. On the other hand, the calein C derivative (3) was the least cytotoxic of all the compounds tested. These results are promising and suggest the importance of studying sesquiterpene lactones isolated from C. pinnatifida in terms of antitumor activity, especially considering the effects of α,β-unsaturated carbonyl systems.